Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. Read more about Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. Read more about Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism.
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. Read more about CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.
Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4. Read more about Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4.
Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. Read more about Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.
Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. Read more about Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system.
Reprogramming of CTLs into natural killer-like cells in celiac disease. Read more about Reprogramming of CTLs into natural killer-like cells in celiac disease.
Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. Read more about Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment.
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. Read more about Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. Read more about Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen.
